APA (7th ed.) Citation

N, D., M, S., S, S., BH, O., & A, S. (2017). Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer. Anticancer research, 37(10), 5533. https://doi.org/10.21873/anticanres.11985

Chicago Style (17th ed.) Citation

N, Dadi, Stanley M, Shahda S, O'Neil BH, and Sehdev A. "Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer." Anticancer Research 37, no. 10 (2017): 5533. https://doi.org/10.21873/anticanres.11985.

MLA (9th ed.) Citation

N, Dadi, et al. "Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer." Anticancer Research, vol. 37, no. 10, 2017, p. 5533, https://doi.org/10.21873/anticanres.11985.